Cindy Jacobs
President at ACHIEVE LIFE SCIENCES, INC.
Net worth: 139 785 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Stewart | M | 65 |
Renown Pharmaceuticals Pvt Ltd.
 Renown Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Renown Pharmaceuticals Pvt Ltd. manufactures pharmaceutical products. The private company is based in Vadodara, India. The company was founded in 2005. Richard Alistair Balfour Stewart has been the CEO of the Indian company since 2016. | 9 years |
| John Bencich | M | 47 | 10 years | |
| Steven Gillis | M | 71 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT.
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | 12 years |
| Ari Nowacek | M | - |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | 5 years |
| Anthony Clarke | M | 68 |
Renown Pharmaceuticals Pvt Ltd.
Renown Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Renown Pharmaceuticals Pvt Ltd. manufactures pharmaceutical products. The private company is based in Vadodara, India. The company was founded in 2005. Richard Alistair Balfour Stewart has been the CEO of the Indian company since 2016. | 9 years |
| Alan C. Rigby | M | - |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | 5 years |
| Vaughn Himes | M | 63 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 5 years |
| Stuart Duty | M | 59 | 1 years | |
| Thomas King | M | 69 | 1 years | |
| Bridget Martell | M | 58 | 4 years | |
| Thomas Sellig | M | 57 | 1 years | |
| Myles James Watts | M | 73 |
Montana State University
| 46 years |
| Michael J. Weickert | M | - |
Pacylex Pharmaceuticals, Inc.
 Pacylex Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Pacylex Pharmaceuticals, Inc. offers medicine solutions for cancers. The company is based in Edmonton, Canada. The CEO of the Canadian company is Michael J. Weickert. | - |
| Ramesh Jatia | M | - |
Renown Pharmaceuticals Pvt Ltd.
Renown Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Renown Pharmaceuticals Pvt Ltd. manufactures pharmaceutical products. The private company is based in Vadodara, India. The company was founded in 2005. Richard Alistair Balfour Stewart has been the CEO of the Indian company since 2016. | - |
| Colin Goddard | M | 64 |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | 5 years |
| Jonathan Lanfear | M | 55 |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | 3 years |
| Jaime Xinos | F | - | 7 years | |
| Jerry Wan | M | 42 | 7 years | |
| Ryan Heit | M | - |
Pacylex Pharmaceuticals, Inc.
Pacylex Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Pacylex Pharmaceuticals, Inc. offers medicine solutions for cancers. The company is based in Edmonton, Canada. The CEO of the Canadian company is Michael J. Weickert. | - |
| Mark Huson | M | - |
Pacylex Pharmaceuticals, Inc.
Pacylex Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Pacylex Pharmaceuticals, Inc. offers medicine solutions for cancers. The company is based in Edmonton, Canada. The CEO of the Canadian company is Michael J. Weickert. | - |
| Ruggero De Maria | M | - |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Scott Daniel Cormack | M | 59 |
OncoGenex Technologies, Inc.
 OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | 8 years |
| Mark McDade | M | 69 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 6 years |
| Martin Mattingly | M | 66 | 13 years | |
| Thomas DeZAo | M | 66 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 3 years |
| Caroline Loewy | F | 58 | 26 years | |
| Carl Anderson | M | - |
Montana State University
| 5 years |
| Cynthia Shumate | F | 62 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 7 years |
| Steven Reed | M | 73 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 10 years |
| Monica Krieger | M | 75 |
OncoGenex Technologies, Inc.
OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 9 years |
| H. Parker | F | 68 | 11 years | |
| Jay Moyes | M | 70 | 6 years | |
| Pat Murphy | M | - |
Washington State University
| 5 years |
| Donald Joseph | M | 70 | 6 years | |
| Kathleen McKereghan Deeley | F | - |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | - |
| Maura Robbins | F | - |
Washington State University
| 4 years |
| Chuck Williams | M | - |
Washington State University
| 4 years |
| Janet Maria Welcher | F | - |
Washington State University
| 4 years |
| Elaine Yong | F | 65 |
Washington State University
| 4 years |
| Adrian Thomas Hickey | M | 71 |
Washington State University
| 4 years |
| Robert Herman | M | 64 |
Washington State University
| 4 years |
| Joseph Talamo | M | 55 |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | 3 years |
| Janet Lynn Bien | F | 60 |
Washington State University
| 4 years |
| Richard D. Strong | M | - |
Washington State University
| 4 years |
| Kathleen Karloff | F | 69 |
Montana State University
| 4 years |
| Gong Chin Ong | M | 55 |
Washington State University
| 4 years |
| Ventje Chandraputra Suardana | M | 64 |
Washington State University
| 2 years |
| Jeff Brown | M | - |
Washington State University
| 4 years |
| John Dubay | M | - |
Washington State University
| 5 years |
| Michael Dey | M | 72 |
Washington State University
| 3 years |
| Jonathan Morris | M | - |
Washington University School of Medicine
| 4 years |
| Myles Hamilton | M | - |
Washington State University
| 2 years |
| Iris Fujiura | F | - |
Washington State University
| 4 years |
| Steve Trabun | M | - |
Washington State University
| 3 years |
| John Read | M | - |
Washington State University
| 1 years |
| Dean Alan Smiley | M | - |
Washington State University
| 4 years |
| Brock M. Vann | M | - |
Washington State University
| 4 years |
| Richard Fohn | M | - |
Washington State University
| 4 years |
| Jim Brown | M | - |
Washington State University
| 4 years |
| Yoon-Song Ham | M | 63 |
Washington State University
| 4 years |
| Bradley Carlson | M | 71 |
Washington State University
| 4 years |
| Chris Jensen | M | - |
Washington State University
| 4 years |
| Anthony Chalfant | M | 62 |
Washington State University
| 4 years |
| Bum-Soo Kim | M | 64 |
Washington State University
| 4 years |
| Eric M. Struhsacker | M | - |
Montana State University
| 1 years |
| Ashok Jhunjhunwala | M | 70 |
Washington State University
| 2 years |
| Phillip C. Ohl | M | - |
Washington State University
| 4 years |
| Gary W. Christianson | M | 69 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 6 years |
| Kenneth S. Eickerman | M | 66 |
Washington State University
| 4 years |
| Michael J. Buckley | M | 73 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 2 years |
| Cory Pulfrey | M | - |
Montana State University
| 4 years |
| Mark Jensen | M | 63 |
Washington State University
| 4 years |
| Douglas James Jackson | M | - |
Washington State University
| 4 years |
| Michael Bigham | M | 66 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 2 years |
| James Jornlin | M | 63 |
Washington State University
| 4 years |
| James F. Shepard | M | 85 |
OncoGenex Technologies, Inc.
OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | - |
| James Shepherd | M | 71 |
OncoGenex Technologies, Inc.
OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | - |
| Phupinder Gill | M | 63 |
Washington State University
| 4 years |
| Chris Laird | M | - |
OncoGenex Technologies, Inc.
OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | - |
| Eric A. DeJong | M | - |
Washington State University
| 4 years |
| Geoffrey Kelley | M | - |
Washington State University
| 4 years |
| Phing Cern Yap | M | 61 |
Washington State University
| 4 years |
| Andreas Skibiel | M | - |
Washington State University
| 4 years |
| Jeff Parker | M | - |
Washington State University
| 4 years |
| Rob Klee | M | - |
Washington State University
| 4 years |
| Gary T. Elliott | M | - |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 3 years |
| John Stephenson | M | - |
Washington State University
| 4 years |
| Vic Leverett | M | 59 |
Washington State University
| 4 years |
| Randall W. Bell | M | - |
Washington State University
| 4 years |
| Charles Richardson | M | 72 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 10 years |
| Karin Jo Lagerlund | F | - |
Washington State University
| 4 years |
| Neil James Clendeninn | M | 74 |
OncoGenex Technologies, Inc.
OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | 4 years |
| Dennis Vermillion | M | 62 |
Washington State University
| 4 years |
| Stephen Charles Anderson | M | 61 |
OncoGenex Technologies, Inc.
OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | - |
| Mark L. Peterson | M | - |
Washington State University
| 3 years |
| Eric Bell | M | - |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 2 years |
| James Bell | M | 59 |
Washington State University
| 4 years |
| Matthew L. Tripp | M | - |
Washington State University
| 3 years |
| R. Gregory Ferrer | M | 68 |
Washington State University
| 4 years |
| Roy Bade | M | 62 |
Washington State University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 76 | 76.00% |
| Canada | 10 | 10.00% |
| India | 3 | 3.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cindy Jacobs
- Personal Network
